FDA labeling · pregnancy and lactation
Pregnancy and lactation sections in an FDA-approved label organize available evidence, clinical considerations and data for a specific product. They are not a universal risk ranking or a substitute for individualized clinical decisions.
Find the current product label first
Drugs@FDA lets readers search approved human drugs by name, active ingredient or application number. For prescription brand-name drugs, the database typically includes the most recent FDA-approved prescribing information and patient labeling when available. The application record matters because similarly named products, formulations or manufacturers can have different documents.
An editor should record the application number, label revision date and relevant section heading. A web result or saved PDF can be authentic but outdated, so version control is part of the medical claim.
Keep three kinds of information separate
- Risk summary: the label’s concise description of available human, animal and pharmacologic evidence.
- Clinical considerations: issues the label asks clinicians to weigh, such as disease-associated risk or monitoring.
- Data: the studies, reports or other evidence supporting the summary.
A report should not quote one sentence from the data section while omitting the population, limitations or accompanying clinical considerations. Absence of data is not evidence of no risk, and an observed association does not automatically prove causation.
Current narrative labeling is designed to communicate evidence and clinical context. Reducing it to a simple “safe” or “unsafe” label removes uncertainty and patient factors that the official document preserves.
A safe editorial checklist
- Match the exact product, route, formulation and application.
- Confirm the label revision date and any later FDA action.
- Attribute findings to the label rather than editorial inference.
- State whether evidence concerns pregnancy, lactation or reproductive potential.
- Do not recommend starting, stopping or changing treatment.
What readers can verify next
A pregnant or breastfeeding reader should discuss the current label and personal circumstances with an appropriate licensed clinician. Acne treatment is one example where reproductive context can shape medication counseling; this patient-facing spironolactone acne evaluation guide shows how medication history and individual risk questions can be organized before a clinical visit. The newsroom can explain where evidence appears; it cannot balance the risks of a condition and its treatment for an individual.